A second explanation for the altered tumour, BC and cfDNA allele frequencies is also based on the assumption that participant 1 is germline heterozygous at the TP53 and HRAS SNPs, but that they are also mosaic for LOH in certain cell lineages following an early somatic event, including the haematopoietic progenitor cell population. The gene discussed is HRAS; the disease is breast cancer.